myelofibrosis | consensus or controversy? documenting and discussing clinical investigators’ prac...
Published 6 months ago • 16 plays • Length 56:48Download video MP4
Download video MP3
Similar videos
-
2:41
myelofibrosis clinical trial participation | how does it move research forward?
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:02
myelofibrosis: unmet needs
-
5:26
myelofibrosis explained: what you need to know
-
2:04
preview of our new video tutorial “how to diagnose primary myelofibrosis”
-
20:01
primary myelofibrosis - overview (presentation, pathophysiology, investigation, treatment)
-
9:56
myelofibrosis: diagnosis and risk stratification
-
2:19
myelofibrosis risk stratisfication
-
2:07
case presentation: primary myelofibrosis
-
4:20
primary myelofibrosis: risk stratification
-
2:02
analyses from comfort trials of ruxolitinib for myelofibrosis
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
1:00
22 1 subdoublet versus single agent ruxolitinib in myelofibrosis
-
2:59
what is myelofibrosis?
-
1:36
the role of molecular markers in patient selection for transplantation in myelofibrosis
-
4:07
diagnosis/risk classification for primary myelofibrosis
-
5:20
identifying a diagnosis of myelofibrosis
-
1:57
challenges in myelofibrosis management
-
5:14
one thousand patients with primary myelofibrosis: the mayo clinic experience